ID Screen® SARS-CoV-2-N IgG Indirect ELISA

A highly reliable serology test to detect IgG antibodies against SARS-CoV-2.

Indirect semi-quantitative ELISA for the specific detection of IgG antibodies against the nucleocapsid of SARS-CoV-2 in human serum and plasma.



  • Approved by French authorities further to its evaluation by the French National Reference Centre
  • High sensitivity and specificity (99.9%) ensures accurate results, with clear discrimination of positive and negative samples
  • Excellent specificity and high positive predictive value, even in low prevalence areas, means a positive result reliably indicates if a person has been exposed to the virus and if the patient has developed antibodies

Rapid and easy-to-use:

  • Use manually or with any open automated immunoassay platform
  • Ready-to-use reagents
  • Results in 95 minutes
  • Possibility to operate on inactivated serum/plasma samples to guarantee operator’s safety

This product is CE marked and available for immediate shipping.


Download the IDvet Press Release of May 7th, 2020

Download the Product Presentation

MethodSemi-quantitative indirect ELISA
SpecimensSerum or plasma
Coated antigenPurified recombinant antigen
ConjugateProtein G-HRP conjugate (concentrated 10X)
Ordering information
Kit format4 plates8 plates
Plate format12 x 8-well strips12 x 8-well strips